Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

Healthcare Cannabis
FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

FSD Pharma Inc > FSD Pharma my thoughts for today
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(137)
•••
Post by DavidRosenbergon Feb 04, 2022 11:04am
71 Views
Post# 34397611

FSD Pharma my thoughts for today

FSD Pharma my thoughts for todayhttps://www.fsdpharma.com

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)

I am a shareholder

FSD Pharma has 3 drug candidates check out the website to learn more.

What makes them unique? They have a new approach to combat Multiple Sclerosis by restoring the damage that was done to the myelin sheath.

Im sharing this info in hopes that someone important can read it a potential cure for MS, in preclinical mouse models with auto immune multiple sclerosis the mouse was cured using the drug that FSD Pharma has. Human trials are yet to be started.

Then they have a pyschoactive drug candidate awaiting patent that used #artificialintelliegence / AI to create a completely new molecule to combat major depressive disorder which is a neuropsychiatric disorder.

Lastly a new phase 2 indication is currently being analyzed for inflammatory conditions ?

FSD PEA short form for Palmitoylethanolamide , a potent anti inflammatory drug they have the ultramicronized form of this substance and the patent is good until 2034.

and most important of all they have a strong biotech team based out of Canada via University Health Network and University of Toronto led by Lakshmi Kotra.

I wish more #analyst 's were able to cover this story. #Lifesci #SternIR #CoreIR #Argotpartners #soleburytrout #BurnsMcClellan #kcsa #Pfizer #Moderna #Sanofi #Merck #JNJ #Jpmorgan #Goldmansachs #westwicke

$HUGE #Nasdaq #Biotech #Healthcare #Institutional #Lifescience #MultipleSclerosis #Remyelination #Neurodegenerative #Inflammatory #MajorDepression #Pharmaceuticals #MS #demyelinating #novartis #GlaxoSmithKline
#EliLilly #roche #abbvie #health
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities